Management of cardiogenic shock complicating acute myocardial infarction: A review

Clinical Cardiology
Ashish H ShahAnkur Kalra

Abstract

Despite advances in percutaneous coronary interventions and their widespread use, mortality in patients presenting with acute myocardial infarction (MI) complicated by cardiogenic shock (CS) has remained very high, and treatment options are limited. Limited evidences exist, supporting many of the routinely used therapies in treating these patients. In the present article, we discuss CS complicating MI in general and an update on the currently available treatment options, including inotropes and vasopressor, coronary revascularization, mechanical circulatory support devices, mechanical complications, and long-term outcomes.

References

May 10, 1973·The New England Journal of Medicine·S ScheidtA Kantrowitz
Aug 15, 1994·The American Journal of Cardiology·M FerrarioC Montemartini
Feb 19, 1999·Circulation Research·H HupfH Schunkert
Jul 3, 1999·Annals of Internal Medicine·S M HollenbergJ E Parrillo
Oct 10, 2002·The American Journal of Cardiology·Harold L DauermanUNKNOWN Global Registry of Acute Coronary Events. GRACE Investigators
Oct 23, 2002·Circulation·Milton PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
Jan 23, 2003·Circulation·Michael H PicardUNKNOWN SHOCK Trial. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK
Apr 23, 2003·Journal of the American College of Cardiology·Alice K JacobsJudith S Hochman
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Feb 3, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ralf HolzerZiyad M Hijazi
Feb 12, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Patrick H McNultyLawrence I Sinoway
Jul 27, 2005·Archives of Internal Medicine·Shun KohsakaUNKNOWN SHOCK Investigators
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
Mar 30, 2006·American Heart Journal·Harmony R ReynoldsMichael H Picard
May 26, 2006·Journal of Cardiothoracic Surgery·Thomas A BarkerIan S Morgan
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Judith S HochmanUNKNOWN SHOCK Investigators
Jan 4, 2007·JAMA : the Journal of the American Medical Association·UNKNOWN APEX AMI InvestigatorsFrans Van de Werf
Mar 28, 2007·JAMA : the Journal of the American Medical Association·UNKNOWN TRIUMPH InvestigatorsJudith S Hochman
Feb 6, 2008·Circulation·Harmony R Reynolds, Judith S Hochman
Sep 4, 2008·Circulation·Christopher B Overgaard, Vladimír Dzavík
Sep 17, 2008·Journal of Intensive Care Medicine·Kanu ChatterjeeAndrew Michaels
May 21, 2009·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Elliot J SmithMartin T Rothman

❮ Previous
Next ❯

Citations

Apr 10, 2021·Journal of Cardiac Surgery·Luis R P DallanFabio B Jatene
May 7, 2021·Current Heart Failure Reports·Alexandra E SperryMichael Ibrahim
Jun 1, 2021·Interventional Cardiology Clinics·Katherine J KunkelMir B Basir
Jan 28, 2022·Yonsei Medical Journal·Yu Ri KimUNKNOWN Other KAMIR-NIH Registry Investigators
Jan 25, 2022·Experimental and Therapeutic Medicine·Ying ZhangJun Xiao

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
coronary artery bypass

Clinical Trials Mentioned

NCT03677180

Software Mentioned

TandemHeart
Impella
HeartWare
CentriMag

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.